Dr. Meeker added, "On behalf of the Board and the entire Rhythm team, I thank Ed for his many years of dedicated service and ...
Rhythm Pharmaceuticals is switching up the tempo for its melanocortin-4 receptor (MC4R) agonist Imcivree. After its initial approval more than five years ago to treat certain patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results